Saturday , April 4 2020
Home / venezuela / Approved for the treatment of pediatric multiple sclerosis in Mexico

Approved for the treatment of pediatric multiple sclerosis in Mexico



[ad_1]

Mexico.- Children aged 10 to 17 years with multiple sclerosis in Mexico now have the best treatment option that helps them to reduce up to 83% of recurrences, said Tuesday a specialist.

According to Dr. Leticia Munive, pediatric neurologist, this lip treatment that has already been used in the adult population in the public and private systems, will help young have a better quality of life.

"The drug not only helps to reduce the frequency of relapses, but slows the progression of the disease and its damage," said the expert, with the & # 39 is an active member of the Mexican Society of Pediatric Neurology.

The expert explained that vehicles with 39 & # is a degenerative disease affecting the central nervous system and generates from neurological damage.

To be an autoimmune disease, defense system wearing themselves flammable and insulating coating (myelin) neurons modifies, reduces or blocks nerve impulses affecting several functions in the body.

It is estimated that, worldwide, one out of every 100,000 children may have the disease, but also in countries such as Mexico, the estimated amount is increased to 2.5 per 100,000 children.

In this regard, Dr. Miriam Jimenez, director of the neuroscience therapeutic area in the pharmaceutical company Novartis, says that although it is a multifactorial disease, identified several factors that increase the risk of developing it.

Among them, he said, they & # 39 are obesity and passive smoking, while having a family member of the & # 39; and morbidity rise by 5% risk of suffering and the number rises to 35% if the family & # 39; and there are some other autoimmune diseases.

The specialist noted that although it is a degenerative disease, if present in the younger age progression is usually slow, but to be more aggressive, so that disability and the damage accumulates.

The main problem, as the experts agreed with the & # 39 is early diagnosis as being somewhat non-specific symptoms, usually not detected, as in adults.

He noted that the TC in pediatric patients may be confused with diseases such as systemic lupus erythematosus, Behcet's disease, neurosarcoidosis Angiitis in Central, tumors, infections, neurometabolic and hereditary diseases of the nervous system.

In this regard, Dr. Hilda Patricia Cervera, a specialist in psychiatry for children, youth and adults, said they have emotional symptoms that can warn of disease.

"Children have stress, fatigue, anxiety and depression. They have a lot of psychological disorders and even reach their diagnosis of attention deficit disorder and hyperactivity, when in fact the EM ", he said.

Some of the children, he said, can be diagnosed within a few weeks or years, which means that the already presented some harm upon detection of the disease.

Experts have called for raising awareness about the disease and parents are advised to any suspicion that their children may have this condition, contact your doctor to have a timely diagnosis and appropriate treatment. EFE

[ad_2]
Source link